Ancestry of pink disease (infantile acrodynia) identified as a risk factor for autism spectrum disorders

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 74, Issue 18, 2011, Pages 1185-1194

  Shandley, Kerrie ^a   Austin, David W ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MERCURY;

ACRODYNIA; ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; DOWN SYNDROME; EPILEPSY; FEMALE; FRAGILE X SYNDROME; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS;

ACRODYNIA; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COHORT STUDIES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS; HUMANS; INFANT; MALE; MERCURY; MIDDLE AGED; POISONS; PREVALENCE; QUESTIONNAIRES;

CORTICIUM SALMONICOLOR;

EID: 79961095240     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2011.590097     Document Type: Article

References (44)

1. Adams, J. B., Baral, M., Geis, E., Mitchell, J., Ingram, J., Hensley, A., Zappia, I., Newmark, S., Gehn, E., Rubin, R. A., Mitchell, K., Bradstreet, J., and el-Dahr, J. M. 2009. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J. Toxicol. Article ID 532640, 7 p.
2. Agency for Toxic Substances and Disease Registry. 1999. Toxicological profile for mer-cury. Atlanta, GA. http://www.atsdr.cdc.gov/ toxprofiles/tp.asp?id=115&tid=24
3. Austin, D. W., and Shandley, K. 2008. An Investigation of porphyrinuria in Australian children with autism. J. Toxicol. Environ. Health A71:1403-5.
4. Austin, D. W. 2008. An epidemiological anal-ysis of the 'autism as mercury poison-ing' hypothesis. Int. Risk. Safety Med. 20: 135-40
5. Australian Bureau of Statistics. 1998. 4102.0\- Australian Social Trends, 1998. http://www. abs.gov.au/ausstats/absat.NSF/2f762f95845 417aeca25706c00834efa/1f6bee4052f3fb4 9ca2570ec00192aa1!OpenDocument
6. Bernard, S., Enayati, A., Redwood, H., and Binstock, T. 2001. Autism: A novel form of mercury poisoning. Med. Hypoth. 56: 463-71.
7. Bivings, L., and Lewis, G. 1949. Acrodynia: A new treatment with BAL. J. Pediatr. 32: 63-65.
8. Bivings, L. 1949. Acrodynia: A summary of BAL therapy reports and a case report of calomel disease.J. Pediatr. 34: 322-24.
9. Bradstreet, J., Geier, D. A., Kartzinel, J. J., Adams J. B., and Geier, M. R. 2003. A case-control study of mercury burden in children with autistic spectrum disorders.J. Am. Phys. Surg. 8: 76-79.
10. Buckmeister, L. 2004. Medication for atten-tion deficit/hyperactivity disorder (ADHD): An analysis by Federal Electorate (200103). http://www.aph.gov.au/library/pubs/RB/2004-05/05rb02.htm
11. Centers for Disease Control and Prevention. 2007. Surveillance Summaries. Feb. 9, 56 (no. SS-1). Morbidity and Mortality Weekly Report. http://www.cdc.gov/mmwr/ pdf/ss/ss5601.pdf
12. Charman, T., Pickles, A., Chandler, S., Wing, L., Bryson, S., Simonoff, E., Loucas, T., and Baird, G. 2009. Commentary: Effects of diagnostic thresholds and research vs service and administrative diagnosis on autism prevalence. Int.J. Epidemiol. 38: 1234-38.
13. Curtis, H. A., Ferguson, S. D., Kell, R. L., and Samuel, A. H. 1987. Mercury as a health hazard.Arch. Dis. Child. 62: 293-95 (Pubitemid 17056637)
14. Down Syndrome Association of Victoria. 2009. About Down syndrome. http://www.dsav. asn.au/AboutDs/aboutDS.html
15. Emsley, J. 2005. The elements ofmurder: A his-toryofpoisoning. Oxford: Oxford University Press
16. Fragile XAssociation of Australia. 2009. Today is fragile X awareness day. http://www.fragilex. org.au/2009/awareness-day-fragilex
17. Gallagher, C. M., and Goodman, M. S. 2010. Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997-2002. J. Toxicol. Environ. Health A 73:1665-77.
18. Geier, D. A., and Geier, M. R. 2007. A prospec-tive study of mercury toxicity biomarkers in autistic spectrum disorders. J. Toxicol. Environ. Health A 70: 1723-30. (Pubitemid 47450885)
19. Geier, D. A., and Geier, M. R. 2006a. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported fol-lowing DTP and Hib vaccine in comparison to DTPH vaccine in the United States. J. Toxicol. Environ. Health A 69: 1481-95.
20. Geier, D. A., and Geier. M. R. 2006b. A clinical and laboratory evaluation of methio-nine cycle\-Transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res. 66: 182-188. (Pubitemid 44413279)
21. Geier, D. A., Kern, J. K., Garver, C. R., Adams, J. B., Audhya, T., Nataf, R., and Geier, M. R. 2009. Biomarkers of environmental toxicity and susceptibility in autism. J. Neurol. Sci. 280: 101-8.
22. Hendry, W. F., AHern, R. P., and Cole, P. J. 1993. Was Young's syndrome caused by exposure to mercury in childhood? Br. Med. J. 307: 1579-82.
23. Holmes, A. S., Blaxill, M. F., and Haley, B.E. 2003. Reduced levels of mercury in first baby haircuts of autistic children. Int. J. Toxicol. 22:277-85. (Pubitemid 37075365)
24. Hviid, A., Stellfeld, M., Wohlfahrt, J., and Melbye, M. 2003. Association between thimerosal-containing vaccine and autism.J. Am. Med. Assoc. 290:1763-66. (Pubitemid 37430627)
25. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, l., Gaylor, D. W., and Neubrander, J. A. 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80: 1611-1617. (Pubitemid 41103861)
26. Leys, D. 1950. A review of infantile acrodynia. Arch. Dis. Child. 25:302-310.
27. MacDermott, M. A., Williams, K., Ridley G., Glasson, E., and Wray J. 2007. The preva-lence of autism in Australia. Can it be estab-lished from existing data? http://autismaus. com.au/uploads/pdfs/PrevalenceReport.pdf
28. Mutter, J., Naumann, J., Schneider, R., Walach, H., and Haley, B. 2005. Mercury and autism: Accelerating evidence? Neuro. Endocrinol. Lett. 26:439-446. (Pubitemid 43013711)
29. Nataf, R., Skorupka, C., Amet, L., Lam, A., Springbett, A., and Lathe, R. 2006. Porphyrinuria in childhood autistic disor-der: Implications for environmental toxicity. Toxicol. Appl. Pharmacol. 214: 99-108.
30. Oka, E., Ohtsuka, Y., Yoshinaga, H., Murakami, N., Kobayashi, K., and Ogino, T. 2006. Prevalence of childhood epilepsy and distribution of epileptic syndromes: A population-based survey in Okayama, Japan. Epilepsia 47: 626-30. (Pubitemid 43351569)
31. Palmer, R. F., Blanchard, S., Stein, Z., Mandell, D., and Miller, C. 2006. Environmental mercury release, special education rates, and autism disorder: An ecological study of Texas. Health Place 12: 203-9. (Pubitemid 41774048)
32. Palmer, R. F., Blanchard, S., and Wood, R. 2009. Proximity to point sources of envi-ronmental mercury release as a predictor of autism prevalence. Health Place 15: 18-24.
33. Rocaz, C. 1933. Pink disease (infantile acro-dynia), trans. I. J. Wood from L'Acrodynie Infantile. London: Martin Hopkinson Ltd.
34. Sakamoto, M., Murata, K., Kubota, M., Nakai, K., and Satoh, H. 2010. Mercury and heavy metal profiles of maternal and umbilical cord RBCs in Japanese population. Ecotoxicol. Environ. Safety 73: 1-6.
35. Selter, P. 1903. Über Trophodermatoneurose. Verh. Ges. Kinderheilkd. (Cassel) 20: 45-50.
36. Sridharan, R. 2002. Epidemiology of epilepsy. Curr. Sci. 82: 664-70. (Pubitemid 135698160)
37. Swift, H. Transactions. Paper presented at the Tenth Session Australasian Medical Congress, Auckland, New Zealand, 1914.
38. Verstraeten, T., Davis, R. L., DeStefano, F., Lieu, T. A., Rhodes, P. H., Black, S. B., Shinefield, H., and Chen, R. T. 2003. Safety of thimerosal-containing vaccines: A two-phased study of computerized health main-tenance organization databases. Pediatrics 112: 1039-48. (Pubitemid 37339554)
39. Warkany, J., and Hubbard, D. M. 1951. Adverse mercurial reactions in the form of acrodynia and related conditions. Am. J. Dis. Child. 81: 335-73.
40. Warkany, J., and Hubbard, D. M. 1948. Mercury in the urine of children with acro-dynia. Lancet 1: 829-38.
41. Wen, X. 1997. The definition andprevalence of intellectual disability in Australia. Australian Institute of Health and Welfare (AIHW) Catalogue no. DIS 2. Canberra: AIHW. http://www.aihw.gov.au/publications/index. cfm/title/94
42. Williams, H., and O'Reilly R. N. 1959. Bronchiectasis in children: Its multiple clin-ical and pathological aspects. Arch. Dis. Child. 34: 192-201.
43. Windham, G. C., Zhang, L., Gunier, R., Croen, L.A., and Grether, J. 2006. Autism spectrum disorders in relation to distribution of haz-ardous air pollutants in the San Francisco Bay air. Environ. Health Perspect. 114: 1438-44. (Pubitemid 44314771)
44. Wood, A. J., and Wood, I. 1935. Pink disease. Br. Med. J. 2: 527-31.